search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • What's New in Practice Management & Payment

    AMA Releases an Interactive Web-based Tool for MIPS

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

  • 2018 ID Week logo final
  • News from IDSA and Journals

    12/1/2017

    Statement on World AIDS Day 2017

    Read More >>

    On World AIDS Day, while we recognize the progress made against HIV globally, we must measure that progress against the urgent needs that remain. 

  • CDC and FDA Alerts

    12/1/2017 1:11:40 PM

    Merck Receives FDA Approval for ISENTRESS

    Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ISENTRESS® (raltegravir), the company’s integrase inhibitor, for use in combination with other antiretroviral agents, for the treatment of HIV-1 in neonates – newborn patients from birth to four weeks of age – weighing at least 2 kg.

    11/27/2017 1:37:12 PM

    People in Four States May Be Drinking Contaminated Raw Milk

    The Centers for Disease Control and Prevention is warning people in the states of Connecticut, New Jersey, New York and Rhode Island, who might have consumed contaminated raw milk and milk products to visit their doctor. 

    11/27/2017 2:05:50 PM

    FDA approves first two-drug regimen for certain patients with HIV

    FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1).

    10/24/2017 5:06:53 PM

    Advice for Health Care Providers Treating Patients in or Recently Returned from Hurricane-Affected Areas, Including Puerto Rico and the US Virgin Islands

    The Centers for Disease Control and Prevention (CDC) is working with federal, state, territorial, and local agencies and global health partners in response to recent hurricanes.

    10/23/2017 1:28:09 PM

    FDA MedWatch - Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

    SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. 

    10/19/2017 3:04:38 PM

    CDC updates guidance for infants born to mothers with possible Zika virus infection during pregnancy

    The Centers for Disease Control and Prevention (CDC) today issuedupdated interim clinical guidance for health care providers caring for infants born to mothers with possible Zika virus infection during pregnancy.

    10/5/2017 6:54:35 PM

    FDA approves first test for screening Zika virus in blood donations

    FDA approves first test for screening Zika virus in blood donations The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. 

    10/4/2017 1:14:59 PM

    Potentially blinding complication following intraocular injections of compounded vancomycin formulation - Drug Information Update

    Hemorrhagic occlusive retinal vasculitis (HORV) is a rare, potentially blinding postoperative complication that has been observed in dozens of patients who have received intraocular injections of vancomycin (anti-infective) formulations toward the end of otherwise uncomplicated cataract surgeries.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site